We consider Scatec’s Q1 report a solid status report, showing that the equity story is evolving as planned with: 1) asset sales reducing net debt on a corporate level; and 2) significant scale on growth through 2027e, with ~NOK16bn in remaining EPC revenues to be recognised from projects under construction and in the company’s backlog. The stock is trading at around our core NAV, suggesting that investors are currently getting unannounced growth at no cost. We reiterate our BUY and have raised o...
AkzoNobel: 3% beat on 1Q25 Adj. EBITDA, FY25 guidance maintained at +€1.55bn. BE Semiconductor Industries: 1Q25 results - extending the downcycle. Corbion: Apogee. Just Eat Takeaway.com: 1Q25 Trading Update - no impact on the bid. Kinepolis: 1Q25 preview. KPN: 1Q25 preview. Randstad: Strong 9% high quality beat on 1Q25, 2Q25 outlook looks a touch below. Vår Energi: Fine start of the year, more to come. Vopak: Reasonable start, cashflow developing nicely.
We forecast Q1 proportionate EBITDA 17% above consensus, which we believe likely does not fully reflect announced divestment gains. We see the company benefiting from scale in growth in the coming years and have raised our 2025–2026e proportionate EBITDA by 9% on a higher D&C contribution. With Scatec trading at a discount to underlying values, and delivering on growth and its divestment programme, we find it offers a solid investment case. We reiterate our BUY and have raised our target price t...
ABN AMRO: Strong results ex one-off, capital, cautious outlook. Ahold Delhaize: FY25F outlook calls for consensus downgrade. DEME Group: Preview - FCF machine. Heineken: Nothing missing. Kinepolis: Canadian peer Cineplex 4Q24 results and Jan 2025 box office revenue. Montea: Good results, guidance reiterated, focus on 2025 investments. Randstad: 4Q24 results beat 3% but key drivers miss, 1Q25 outlook disappoints. Var Energi: Raising outlook and dividend
With the Q4 results largely in line with expectations and the mid-point of the 2025 EBITDA guidance 4% below consensus likely due to assumptions about the timing of asset sales and proceeds, we consider Scatec’s Q4 report neutral. We have made limited estimate revisions following the results; we reiterate BUY and have raised our target price to NOK90 (86) based on a higher contribution from ancillary services in the Philippines.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.